Is Novo Nordisk a Hot Stock to Buy Now After its Spectacular Q4?

Two of the most talked-about drugs in the U.S., obesity treatment Wegovy and diabetes medication Ozempic, are made by the same company: Denmark-based Novo Nordisk (NVO -1.80%). There wouldn't be so much chatter if these drugs weren't flying off pharmacy shelves these days, particularly in the case of Wegovy.Solid evidence of this was provided early this week by the company, which released highly encouraging quarterly and annual results featuring plenty of high-growth figures. Let's pick these apart a little ...